Medplus Health Services Ltd

0
BOM:543427 (India)  
₹ 679.15 (-0.18%) Nov 8
105.79
P/B:
5.07
Market Cap:
₹ 81.13B ($ 961.41M)
Enterprise V:
₹ 89.57B ($ 1.06B)
Volume:
15.20K
Avg Vol (2M):
23.75K
Warning! GuruFocus detected 2 Severe warning signs with 543427. Try a 7-Day Free Trial to check it out.
Trade In:
Volume:
15.20K
Market Cap ₹:
81.13B
Market Cap $:
961.41M
105.79
Avg Vol (2M):
23.75K
Enterprise Value ₹:
89.57B
Enterprise Value $:
1.06B
PB Ratio:
5.07
Alerts Website Sources Stock PDF
Dataset
Financial Download GuruFocus Premium Icon Manual of Stocksâ„¢

Business Description

Medplus Health Services Ltd

ISIN : INE804L01022
https://www.medplusindia.com
Opposite IDPL Railway Siding Road, Municipal No: 11-6-56, Survey No. 257 & 258/1, Moosapet, Kukatpally, Hyderabad, TG, IND, 500 037
Compare
Compare
BOM:533259BOM:543616NSE:MONOPHARMABOM:543499BOM:514330BOM:543594BOM:501477BOM:513430WBABSP:RADL3HKSE:00241TSE:3088SAU:4164SHSE:603939TSE:3349SHSE:600998TSE:3391JSE:CLSTSE:3141TSE:9989
Traded in other countries / regions
543427.India
IPO Date
2021-12-23
Description
Medplus Health Services Ltd is a pharmacy retailer. It offers pharmaceutical and wellness products such as medicines, vitamins, medical devices, test kits, and others. The company also offers an omnichannel platform wherein customers can purchase products through stores, place orders over the telephone, online orders, and a Click and Pick facility. Its operating segments include Retail, Diagnostics, and Others.

Financial Strength

6/10
Name Current Vs Industry Vs History
Cash-To-Debt 0.16
Equity-to-Asset 0.53
Debt-to-Equity 0.64
Debt-to-EBITDA 2.43
Interest Coverage 1.5
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 6.08
Distress
Grey
Safe
Beneish M-Score -2.04
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

10/10
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 22
3-Year EBITDA Growth Rate 18.2
3-Year EPS without NRI Growth Rate -0.4
3-Year Book Growth Rate 29.2
Future 3-5Y EPS without NRI Growth Rate Estimate 60.46
Future 3-5Y Total Revenue Growth Rate Estimate 18.36

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 61.38
9-Day RSI 56.57
14-Day RSI 53.98
6-1 Month Momentum % -5.46
12-1 Month Momentum % -18.26

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.98
Quick Ratio 0.43
Cash Ratio 0.31
Days Inventory 100.74
Days Sales Outstanding 0.58
Days Payable 21.78

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -1.77

Profitability Rank

6/10
Name Current Vs Industry Vs History
Gross Margin % 21.42
Operating Margin % 2.53
Net Margin % 1.32
FCF Margin % 1.03
ROE % 4.97
ROA % 2.61
ROIC % 5.46
3-Year ROIIC % 2.49
ROC (Joel Greenblatt) % 8.91
ROCE % 7.68
Years of Profitability over Past 10-Year 6

GF Value Rank

2/10
Name Current Vs Industry Vs History
PE Ratio 105.79
Forward PE Ratio 70.21
PE Ratio without NRI 105.79
PEG Ratio 4.1
PS Ratio 1.39
PB Ratio 5.07
Price-to-Tangible-Book 5.31
Price-to-Free-Cash-Flow 135.45
Price-to-Operating-Cash-Flow 55.92
EV-to-EBIT 48.69
EV-to-Forward-EBIT 29.64
EV-to-EBITDA 21.54
EV-to-Forward-EBITDA 16.21
EV-to-Revenue 1.55
EV-to-Forward-Revenue 1.14
EV-to-FCF 150.94
Price-to-Peter-Lynch-Fair-Value 5.26
Price-to-Graham-Number 5.42
Price-to-Net-Current-Asset-Value 57.65
Earnings Yield (Greenblatt) % 2.05
FCF Yield % 0.73
Forward Rate of Return (Yacktman) % 20.15

Financials (Next Earnings Date:2024-11-29 Est.)

BOM:543427's 30-Y Financials
AAPL
Income Statement Breakdown FY
No Enough Data
AAPL
Balance Sheet Breakdown
No Enough Data
AAPL
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Medplus Health Services Ltd Executives

Details

GF Value: ₹1028.46

BOM:543427

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ₹) 57,780.71
EPS (TTM) (₹) 6.33
Beta 0
Volatility % 11.25
14-Day RSI 53.98
14-Day ATR (₹) 22.422339
20-Day SMA (₹) 670.5075
12-1 Month Momentum % -18.26
52-Week Range (₹) 597.95 - 849.3
Shares Outstanding (Mil) 119.45

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Medplus Health Services Ltd Filings

Filing Date Document Date Form
No Filing Data

Medplus Health Services Ltd Stock Events

Financials Calendars
Event Date Price(₹)
No Event Data

Medplus Health Services Ltd Frequently Asked Questions

What is Medplus Health Services Ltd(BOM:543427)'s stock price today?
The current price of BOM:543427 is ₹679.15. The 52 week high of BOM:543427 is ₹849.30 and 52 week low is ₹597.95.
When is next earnings date of Medplus Health Services Ltd(BOM:543427)?
The next earnings date of Medplus Health Services Ltd(BOM:543427) is 2024-11-29 Est..
Does Medplus Health Services Ltd(BOM:543427) pay dividends? If so, how much?
Medplus Health Services Ltd(BOM:543427) does not pay dividend.

Press Release

Subject Date
No Press Release
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.